Última hora
ESTadej Pogacar pulveriza el récord del Alpe d'Huez en un Tour de Francia marcado por la multitudESJürgen Klopp, nuevo seleccionador de Alemania, promete revivir la selecciónESIncendios en España: Solidaridad y Unidad ante la CatástrofeESIncendios en Ávila y Madrid: Historias detrás del fuegoESIncendio en la Comunidad de Madrid: 10 municipios evacuados y 30.000 personas afectadasESIncendio forestal en Madrid pone en riesgo instalaciones clave de la NASAESFrancia lucha contra incendios forestales descontrolados en el surESGiro inesperado en el caso Plus Ultra: dimisión de directivos y nuevas investigacionesESLa primera ministra japonesa Sanae Takaichi genera controversia con su post sobre exceso de trabajo y escaso sueñoESIncendios y olas de calor: La crisis climática supera la realidad en España y EuropaESTadej Pogacar pulveriza el récord del Alpe d'Huez en un Tour de Francia marcado por la multitudESJürgen Klopp, nuevo seleccionador de Alemania, promete revivir la selecciónESIncendios en España: Solidaridad y Unidad ante la CatástrofeESIncendios en Ávila y Madrid: Historias detrás del fuegoESIncendio en la Comunidad de Madrid: 10 municipios evacuados y 30.000 personas afectadasESIncendio forestal en Madrid pone en riesgo instalaciones clave de la NASAESFrancia lucha contra incendios forestales descontrolados en el surESGiro inesperado en el caso Plus Ultra: dimisión de directivos y nuevas investigacionesESLa primera ministra japonesa Sanae Takaichi genera controversia con su post sobre exceso de trabajo y escaso sueñoESIncendios y olas de calor: La crisis climática supera la realidad en España y Europa
Newsgather

breast_cancer

Estable23 noticias14 fuentesÚltima actualización: 11/7/2026

Últimas noticias

41-year-old mother with metastatic breast cancer overcomes tumor's changing nature with new drugs
En desarrollo
Salud·3/6/2026Resumen IA

41-year-old mother with metastatic breast cancer overcomes tumor's changing nature with new drugs

A 41-year-old mother, "Xiao Ya," successfully battled metastatic breast cancer whose cells changed type three times, from HER2-positive to triple-negative, and finally to HER2-low-positive. New precision drugs, including ADC medications, have helped her overcome the evolving tumor. However, Taiwan's National Health Insurance does not yet cover these treatments for advanced and metastatic HER2-low-positive patients, raising concerns about unequal access to care.

自由时报
2 min de lectura
Trump Nominates Dr. Nicole Saphier for Surgeon General, His Third Pick for 'Nation's Doctor'
En desarrollo
Política·2/5/2026Resumen IA

Trump Nominates Dr. Nicole Saphier for Surgeon General, His Third Pick for 'Nation's Doctor'

President Trump has nominated Dr. Nicole Saphier, a radiologist and former Fox News contributor, as surgeon general — his third pick for the position after previous nominees Dr. Janette Nesheiwat withdrew and Dr. Casey Means failed to secure confirmation. Saphier, who directs breast imaging at Memorial Sloan Kettering Monmouth and hosts a podcast, is expected to face easier confirmation than her predecessor due to her active medical license and alignment with Republican priorities on issues like chronic disease prevention and the MAHA movement.

N
NPR News
4 min de lectura
FDA Advisory Panel Votes Against AstraZeneca's Breast Cancer Drug Camizestrant
En desarrollo
Business·1/5/2026Resumen IA

FDA Advisory Panel Votes Against AstraZeneca's Breast Cancer Drug Camizestrant

AstraZeneca's experimental breast cancer drug camizestrant faced a setback as a U.S. FDA advisory panel voted 6-3 against approval, citing concerns over the SERENA-6 trial design. The Phase 3 trial showed a 56% reduction in disease progression or death, but panel members weren't convinced early switching improved long-term survival. Shares fell 2% in morning trading, though analysts noted the drug's efficacy wasn't dismissed and the issue shouldn't impact AstraZeneca's $80 billion 2030 sales goal.

C
CNBC
1 min de lectura